Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03040986
Title Selumetinib Sulfate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12R Mutations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

pancreatic cancer

Therapies

Selumetinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Los Angeles County-USC Medical Center Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
NCI - Center for Cancer Research Bethesda Maryland 20892 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field